Regulations.gov document
Exhibit 18 Lerman, R. FDA halts trial of cancer drug by Seattle's CTI BioPharma after…
Supporting & Related Material · FDA-2014-P-0814 · posted Apr 1, 2016
Key facts
| Document ID | FDA-2014-P-0814-0016 |
|---|---|
| Title | Exhibit 18 Lerman, R. FDA halts trial of cancer drug by Seattle's CTI BioPharma after patients die, Source http://www.seattletimes.com/business/fda-halts-cti-biopharma-drug-trial-for-detrimental-effect-on-survival/ February 10, 2016 re: Amendment from Center for Responsible Science |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2014-P-0814 |
| Posted | Apr 1, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: